Interestingly, glitazone types of chemical molecules that are used in the clinical treatment of diabetes mellitus were found to have anti-neuroinflammatory action and neuroprotection through central PPAR-γ agonism (Swanson et al., 2011). This evidence concerns the gene PPARG and diabetes mellitus.